Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS 230 MSs of Mediceo Begin to Work as ARs for Sawai
July 4, 2012
-
ORGANIZATION JGA Begins Posting Information on Out-of-Stock Products, Delayed Shipments on Website
July 3, 2012
-
BUSINESS Otsuka, Kyowa Kirin Announce Strategic Alliance in Fields of Diabetes, Oncology
July 2, 2012
-
REGULATORY JPO Rules Actonel Patent Invalid; Ajinomoto Considering Appeal
June 29, 2012
-
ACADEMIA Univ. of Tokyo Hospital’s New “Phase I Unit” to Initiate Trials for Takeda’s TAK-070 for AD
June 28, 2012
-
BUSINESS Eisai to Make Full-Scale Entry into Russian Market; Antiepileptic Agent Obtains Approval
June 28, 2012
-
REGULATORY MHLW Talks to Drug Makers with Facilities Eligible for Exemption from Planned Power Outages
June 27, 2012
-
REGULATORY MHLW Orders Updates from Chugai Following Criticism for Reporting Deficiencies by Roche in US
June 26, 2012
-
ORGANIZATION JPWA, NPhA Confirm Need for Thorough Efforts “at Ground Level” for Distribution Improvements
June 25, 2012
-
REGULATORY MHLW to Strengthen Focus on Dementia with Budget Request for FY2013
June 22, 2012
-
REGULATORY 60% Rule Applied for 3 APIs in June’s Generic Listing
June 22, 2012
-
REGULATORY PMDA’s Science Committee Holds 1st Meeting; Will Work to Improve Review Quality through Exchanges with Researchers
June 20, 2012
-
ORGANIZATION Products from 2nd Round of Development Requests Now Eligible for PDSC Subsidies
June 19, 2012
-
REGULATORY DPJ Approves Draft Bill to Establish 3rd-Party Organization; Will Seek Discussions with Opposition
June 18, 2012
-
BUSINESS Top 100 Products in FY2011: Pronounced Growth for ARB Combinations with Declining Sales of Monodrugs
June 15, 2012
-
BUSINESS Sanofi, Hisamitsu to Form JV for Allergy-Related OTCs, Seen Eyeing Allegra OTC Launch
June 14, 2012
-
REGULATORY Ryukaikon’s Working Team Prepares to Start Operations by End of June; Beginning with Exchange of Opinions between JPWA, NPhA
June 13, 2012
-
BUSINESS Sawai Considers Leveraging “MSs with MR Qualifications” with Medipal Group
June 12, 2012
-
BUSINESS University of Tokyo Hospital to Take Over Development of Takeda’s AD Treatment Candidate
June 11, 2012
-
REGULATORY Expert Subcommittee Begins Discussions on Pricing of Long-Listed Drugs with Focus on Differences from Generic Prices
June 8, 2012
ページ
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…